Reflections on the Implementation of Low-Dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in Spain

Autor: Garrido P, Sánchez M, Belda Sanchis J, Moreno Mata N, Artal Á, Gayete Á, Matilla González JM, Galbis Caravajal JM, Isla D, Paz-Ares L, Seijo LM

Publikováno v: ARCHIVOS DE BRONCONEUMOLOGIA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Lung cancer (LC) is a major public health issue. Despite recent advances in treatment, primary prevention and early diagnosis are key to reducing the incidence and mortality of this disease. A recent clinical trial demonstrated the efficacy of select

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::96eecf41450694fa484d6dd23f4dd5b6
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3373

Cell-free DNA concentration in pleural fluid and serum: quantitative approach and potential prognostic factor in patients with cancer and pleural effusions

Autor: Benlloch S, Martí-Ciriquián JL, Galbis-Caravajal JM, Martín C, Sánchez-Payá J, Rodríguez-Paniagua JM, Romero S, Massutí B

Publikováno v: CLIN LUNG CANCER
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

PURPOSE: The presence of pleural effusions in patients with tumors is often indicative of locally advanced or metastatic disease, and detection of malignancy in effusion samples frequently leads to a disease upstaging. Our purpose was to quantify the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::e7fec81afac015ebd4b2b82c5d69fe44
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8918

Pyoderma gangrenosum in a pulmonary lobectomy surgical wound.

Autor: Balciscueta Coltell I; Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de La Ribera, Alzira, Valencia, España. Electronic address: izas_balcis@hotmail.com., Estors Guerrero M; Servicio de Cirugía Torácica, Hospital Universitario de La Ribera, Alzira, Valencia, España., Martínez Hernández N; Servicio de Cirugía Torácica, Hospital Universitario de La Ribera, Alzira, Valencia, España., Galbis Caravajal JM; Servicio de Cirugía Torácica, Hospital Universitario de La Ribera, Alzira, Valencia, España.

Publikováno v: Cirugia espanola [Cir Esp (Engl Ed)] 2020 Apr; Vol. 98 (4), pp. 237. Date of Electronic Publication: 2019 Jun 14.

CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC.

Autor: Becker JH; Department of Surgery, Division of Cardiothoracic Surgery, University of Illinois at Chicago, Chicago, Illinois.; University of Illinois Hospital & Health Sciences System Cancer Center, University of Illinois at Chicago, Chicago, Illinois.; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois., Gao Y; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois., Soucheray M; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois., Pulido I; Departament de Fisiologia, Facultat de Farmacia, Universitat de València, Burjassot, Spain., Kikuchi E; First department of Medicine, Hokkaido University Hospital, Sapporo, Hokkaido, Japan., Rodríguez ML; Departament de Fisiologia, Facultat de Farmacia, Universitat de València, Burjassot, Spain., Gandhi R; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois., Lafuente-Sanchis A; Department of Molecular Biology, Hospital Universitario de la Ribera, Alzira, Valencia, Spain., Aupí M; Departament de Fisiologia, Facultat de Farmacia, Universitat de València, Burjassot, Spain., Alcácer Fernández-Coronado J; Department of Pathology, Hospital Quirónsalud Valencia, Valencia, Spain., Martín-Martorell P; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain., Cremades A; Department of Pathology, Hospital Universitario de la Ribera, Alzira, Valencia, Spain., Galbis-Caravajal JM; Department of Thoracic Surgery, Hospital Universitario de la Ribera, Alzira, Valencia, Spain., Alcácer J; Department of Pathology, Hospital Quirónsalud Valencia, Valencia, Spain., Christensen CL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ludwig Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Simms P; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois., Hess A; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois., Asahina H; First department of Medicine, Hokkaido University Hospital, Sapporo, Hokkaido, Japan., Kahle MP; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois., Al-Shahrour F; Bioinformatics Unit, Spanish National Cancer Research Centre, Madrid, Spain., Borgia JA; Department of Cell & Molecular Medicine, Rush University Medical Center, Chicago, Illinois., Lahoz A; Biomarkers and Precision Medicine Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Insa A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain., Juan O; Biomarkers and Precision Medicine Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; Department of Medical Oncology, Hospital Universitari I Politècnic La Fe, Valencia, Spain., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bioinformatics Unit, Spanish National Cancer Research Centre, Madrid, Spain., Wong KK; Laura and Isaac Perlmutter Cancer Center, Division of Hematology and Medical Oncology, New York University, New York, New York., Carretero J; Departament de Fisiologia, Facultat de Farmacia, Universitat de València, Burjassot, Spain. tshima2@uic.edu jcarrete@uv.es., Shimamura T; Department of Surgery, Division of Cardiothoracic Surgery, University of Illinois at Chicago, Chicago, Illinois. tshima2@uic.edu jcarrete@uv.es.; University of Illinois Hospital & Health Sciences System Cancer Center, University of Illinois at Chicago, Chicago, Illinois.; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois.

Publikováno v: Cancer research [Cancer Res] 2019 Sep 01; Vol. 79 (17), pp. 4439-4452. Date of Electronic Publication: 2019 Jul 04.

Topography of the sentinel node according to the affected lobe in lung cancer.

Autor: Galbis-Caravajal JM; Servicio de Cirugía Torácica, Del Hospital Universitario de La Ribera, Alcira, Spain., Lafuente-Sanchis A; Servicio de Biología Molecular, Del Hospital Universitario de La Ribera, Crta. Corbera, km. 1, 46600, Alcira, Valencia, Spain. alafuente@hospital-ribera.com., Estors-Guerrero M; Servicio de Cirugía Torácica, Del Hospital Universitario de La Ribera, Alcira, Spain., Martinez-Hernández N; Servicio de Cirugía Torácica, Del Hospital Universitario de La Ribera, Alcira, Spain., Fuster-Diana C; Unidad Funcional de Mama, Del Hospital General Universitario de Valencia, Valencia, Spain., Cremades A; Servicio y de Anatomía Patológica, Del Hospital Universitario de La Ribera, Alcira, Spain., Zúñiga Á; Servicio de Biología Molecular, Del Hospital Universitario de La Ribera, Crta. Corbera, km. 1, 46600, Alcira, Valencia, Spain.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2017 Jul; Vol. 19 (7), pp. 858-864. Date of Electronic Publication: 2017 Jan 27.